HealthEquity Stock Forecast

Stock Price Forecast

The 14 analysts with 12-month price forecasts for HealthEquity stock have an average target of 115, with a low estimate of 89 and a high estimate of 128. The average target predicts an increase of 41.66% from the current stock price of 81.18.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$89	$115	$120	$128
Change	+9.63%	+41.66%	+47.82%	+57.67%

Analyst Ratings

The average analyst rating for HealthEquity stock from 14 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26
Strong Buy	5	4	4	4	4	4
Buy	8	9	9	9	8	9
Hold	2	2	1	1	1	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	1	1	1	1
Total	15	15	15	15	14	14

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Sean Dodge BMO Capital	BMO Capital	Hold → Buy Upgrades $85 → $105	Hold → Buy	Upgrades	$85 → $105	+29.34%	Apr 9, 2026
George Hill Deutsche Bank	Deutsche Bank	Strong Buy Maintains $120 → $128	Strong Buy	Maintains	$120 → $128	+57.67%	Mar 19, 2026
Alexander Paris Barrington Research	Barrington Research	Buy Maintains $125 → $110	Buy	Maintains	$125 → $110	+35.50%	Mar 18, 2026
Alexei Gogolev JP Morgan	JP Morgan	Buy Maintains $129 → $123	Buy	Maintains	$129 → $123	+51.52%	Mar 18, 2026
Daniel R. Perlin RBC Capital	RBC Capital	Buy Maintains $110 → $100	Buy	Maintains	$110 → $100	+23.18%	Mar 18, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

1.43B

from 1.31B

8.57%

from 1.31B

Revenue Next Year

1.55B

from 1.43B

8.42%

from 1.43B

EPS This Year

4.67

from 2.46

89.83%

from 2.46

EPS Next Year

5.39

from 4.67

15.43%

from 4.67

Fiscal Year	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027	FY 2028
Period Ending	Jan 31, 2022	Jan 31, 2023	Jan 31, 2024	Jan 31, 2025	Jan 31, 2026	Jan 31, 2027	Jan 31, 2028
Revenue	756.56M	861.75M	999.59M	1.20B	1.31B	1.43B	1.55B
Revenue Growth	3.13%	13.90%	16.00%	20.03%	9.47%	8.57%	8.42%
EPS	-0.53	-0.31	0.64	1.09	2.46	4.67	5.39
EPS Growth	-	-	-	70.31%	125.69%	89.83%	15.43%
Forward PE	-	-	-	-	-	17.38	15.06
No. Analysts	-	-	-	-	-	17	16

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2027	2028
High	1.5B	1.7B
Avg	1.4B	1.5B
Low	1.4B	1.5B

Revenue Growth

Revenue Growth	2027	2028
High	13.1%	16.3%
Avg	8.6%	8.4%
Low	4.8%	2.4%

EPS Forecast

EPS	2027	2028
High	4.97	6.28
Avg	4.67	5.39
Low	4.46	5.00

EPS Growth

EPS Growth	2027	2028
High	101.9%	34.5%
Avg	89.8%	15.4%
Low	81.3%	7.0%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.